During pregnancy, the occurrence of Sexually Transmitted Infections (STI) is a problem aggravated by the presence of the fetus, which presents difficulties in the use of certain drugs and the physiological adaptations of this phase in the pregnancypuerperal cycle. The World Health Organization (WHO) estimates that 448 million new STIs worldwide occur each year, of which the most frequent are associated with human papillomavirus (HPV), Chlamydia trachomatis, Neisseria gonorrhoeae.
About this chapter
Cite this chapter as:Ana Paula Costa, Ayane Cristina Sarmento, Maria da Conceição Cornetta, Ana Katherine Gonçalves ;
Anti-infective Agents for Sexually Transmitted Infections in Pregnancy, Frontiers in Anti-infective Agents Pregnancy and Anti-Infective Agents (2020) 4: 88. https://doi.org/10.2174/9789811479595120040007
Bentham Science Publisher